Fil LTD Spring Works Therapeutics, Inc. Put Options Transaction History
Fil LTD
- $106 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SWTX
# of Institutions
277Shares Held
73.1MCall Options Held
12MPut Options Held
1.39M-
Vanguard Group Inc Valley Forge, PA7.13MShares$335 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$264 Million0.0% of portfolio
-
Glazer Capital, LLC New York, NY4.11MShares$193 Million6.9% of portfolio
-
State Street Corp Boston, MA2.99MShares$141 Million0.01% of portfolio
-
Tig Advisors, LLC New York, NY2.61MShares$123 Million6.62% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.93B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...